ADARx Pharmaceuticals, Inc. (ADRX)
NASDAQ: ADRX · Real-Time Price · USD
14.27
+0.45 (3.26%)
Nov 18, 2026, 12:11 PM EST - Market open
ADARx Pharmaceuticals Market Cap
ADARx Pharmaceuticals has a market cap or net worth of $1.52 billion as of November 18, 2026. It is the 7,771st most valuable company in the world and the 1,942nd biggest in the United States.
Market Cap
1.52B
Enterprise Value
1.10B
1-Year Change
n/a
Global Rank
Country Rank
#1,942 United States
Category
ChartMarket Cap Chart
Since the IPO on September 25, 2026, ADARx Pharmaceuticals's market cap has decreased from $1.74B to $1.52B, a decrease of -12.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 1.52B | 3.26% |
| Nov 17, 2026 | 1.48B | -1.29% |
| Nov 16, 2026 | 1.50B | -1.41% |
| Nov 13, 2026 | 1.52B | -4.76% |
| Nov 12, 2026 | 1.59B | 12.11% |
| Nov 11, 2026 | 1.42B | -1.99% |
| Nov 10, 2026 | 1.45B | -1.67% |
| Nov 9, 2026 | 1.47B | 4.31% |
| Nov 6, 2026 | 1.41B | -0.45% |
| Nov 5, 2026 | 1.42B | -11.16% |
| Nov 4, 2026 | 1.60B | -7.02% |
| Nov 3, 2026 | 1.72B | 2.09% |
| Nov 2, 2026 | 1.68B | -7.29% |
| Oct 30, 2026 | 1.82B | -4.76% |
| Oct 29, 2026 | 1.91B | -0.56% |
| Oct 28, 2026 | 1.92B | -0.99% |
| Oct 27, 2026 | 1.94B | 1.80% |
| Oct 26, 2026 | 1.90B | 1.02% |
| Oct 23, 2026 | 1.88B | -0.28% |
| Oct 22, 2026 | 1.89B | 3.21% |
| Oct 21, 2026 | 1.83B | -3.11% |
| Oct 20, 2026 | 1.89B | 0.28% |
| Oct 19, 2026 | 1.88B | -0.11% |
| Oct 16, 2026 | 1.89B | -0.28% |
| Oct 15, 2026 | 1.89B | -0.73% |
| Oct 14, 2026 | 1.90B | 0.73% |
| Oct 13, 2026 | 1.89B | -1.50% |
| Oct 12, 2026 | 1.92B | 1.07% |
| Oct 9, 2026 | 1.90B | 0.59% |
| Oct 8, 2026 | 1.89B | 1.99% |
| Oct 7, 2026 | 1.85B | -6.73% |
| Oct 6, 2026 | 1.98B | -2.47% |
| Oct 5, 2026 | 2.03B | 4.38% |
| Oct 2, 2026 | 1.95B | -6.60% |
| Oct 1, 2026 | 2.09B | -2.01% |
| Sep 30, 2026 | 2.13B | -3.37% |
| Sep 29, 2026 | 2.20B | 2.71% |
| Sep 28, 2026 | 2.15B | 23.52% |
| Sep 25, 2026 | 1.74B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Precigen | 1.57B |
| Braveheart Bio | 1.57B |
| Mesoblast | 1.55B |
| uniQure | 1.55B |
| Immunocore Holdings | 1.51B |
| SELLAS Life Sciences Group | 1.51B |
| Rapport Therapeutics | 1.50B |
| Korsana Biosciences | 1.48B |